Therapeutic Asset Ratings

603 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
FULVESTRANT MEK2 Gene Mutation	Memorial Sloan Kettering Cancer Center	P1/2	CCC (52)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Prostate Cancer	Memorial Sloan Kettering Cancer Center	P1/2	CCC (52)
Ipilimumab Malignant Pleural Mesothelioma	Memorial Sloan Kettering Cancer Center	P1/2	CCC (52)
Nivolumab Malignant Pleural Mesothelioma	Memorial Sloan Kettering Cancer Center	P1/2	CCC (52)
Therapeutic Autologous Lymphocytes Leukemia	Memorial Sloan Kettering Cancer Center	P1/2	CCC (52)
Ratg Acute Myelogenous Leukemia	Memorial Sloan Kettering Cancer Center	P3	CCC (51)
68ga-hbed-ipsma Prostate Adenocarcinoma	Memorial Sloan Kettering Cancer Center	P2	CCC (51)
Balstilimab Rectal Carcinoma	Memorial Sloan Kettering Cancer Center	P2	CCC (51)
Botensilimab Rectal Carcinoma	Memorial Sloan Kettering Cancer Center	P2	CCC (51)
Degarelix Myelodysplastic Syndrome	Memorial Sloan Kettering Cancer Center	P2	CCC (51)
Degarelix Non-Hodgkin Lymphoma	Memorial Sloan Kettering Cancer Center	P2	CCC (51)
Dostarlimab Rectum Adenocarcinoma	Memorial Sloan Kettering Cancer Center	P2	CCC (51)
Hpc, Cord Blood Acute Myeloid Leukemia	Memorial Sloan Kettering Cancer Center	P2	CCC (51)
LEUPROLIDE Lymphoma, Non-Hodgkin	Memorial Sloan Kettering Cancer Center	P2	CCC (51)
Tarlatamab Metastatic Prostate Carcinoma	Memorial Sloan Kettering Cancer Center	P2	CCC (51)
Tucatinib Rectal Carcinoma	Memorial Sloan Kettering Cancer Center	P2	CCC (51)
Calcium folinate pentahydrate Urothelial Carcinoma	Memorial Sloan Kettering Cancer Center	P1/2	CCC (51)
Oxycodone Plasma Cell Myeloma	Memorial Sloan Kettering Cancer Center	P3	CCC (50)
18F-ASIS Non-small Cell Lung Cancer	Memorial Sloan Kettering Cancer Center	P2	CCC (50)
Avutometinib Neoplasm	Memorial Sloan Kettering Cancer Center	P2	CCC (50)
Canagliflozin Breast Cancer	Memorial Sloan Kettering Cancer Center	P2	CCC (50)
E-7820 Chronic Myelomonocytic Leukemia	Memorial Sloan Kettering Cancer Center	P2	CCC (50)
Fam-Trastuzumab Deruxtecan-Nxki Breast Cancer	Memorial Sloan Kettering Cancer Center	P2	CCC (50)
POLY((N-(2-HYDROXYPROPYL)METHACRYLAMIDE)-CO-(METHACRYLOYL-GLY-PHE-LEU-GLY AMIDE WITH O-((TRANS-4-AMINOCYCLOHEXYL)CARBAMOYL)FUMAGILLOL)) (~0.91:0.09 X) Breast Cancer	Memorial Sloan Kettering Cancer Center	P2	CCC (50)
DEXAMETHASONE Secondary Central Nervous System Lymphoma (SCNSL)	Memorial Sloan Kettering Cancer Center	P1	CCC (50)

Showing 276 to 300 of 603 assets

PreviousPage 12 of 25Next